News

The acclaimed author of The Innovator's Dilemma explained to hospital leaders what they need to do to disrupt rather than just sustain.

In a panel at the Mayo Clinic Center for Innovation's Transform conference, healthcare leaders went so far as to call current systems "crude" and "corrosive."

The National Institutes of Health says it’s one of the largest data sets ever made public.

Burnout is a problem. This medical school dean says innovation and good old-fashioned empathy can help.

As participants like Apple and Samsung prepare to huddle, Pear Therapeutics sees the upside.

The man who ran Medicare and Medicaid under President Obama speaks out.

Curtis Hanson, MD, sat down to discuss the role of laboratory testing in the pursuit of value-based care.

And what can physicians learn from data linked to questionably prescribed pain meds?

The company’s largest round of funding underscores the strength of a device and an algorithm.

How data led to a discovery that could accelerate the development of new drugs.

Companies like Apple, Fitbit, and Johnson & Johnson are among those in a new pre-certification pilot program.

Why the Canadian genetic medicine startup Deep Genomics earned the money.

"Your IT vision needs to relate to your business: who you want to be and how you want to perform. It’s always in service to that, not just an independent pursuit of gadgetry."

The American public is interested in consumer DNA testing, but lacking in knowledge about genetics and privacy.

Study shows certain apps may help manage mental health symptoms, but does not address speculation that smartphones may have negative mental health impacts overall.

Precision Medicine Group today launched its Precision Value & Health initiative to try to find ways to address that question.

The work presented at EASD demonstrated that patients were able to achieve rapid glucose control and maintain long-term A1C reductions

“It’s a huge validation, coming from the country’s 4th largest insurance company," Cogitativo CEO Gary Velsquez said.

Open-source, collaborative, and blockchain constrained, Morpheo is starting with sleep disorders and looking far beyond.

CMS has launched a survey, and Seema Verma has written an op-ed, intended on garnering new perspectives for the Innovation Center.

The unit will be capable of producing up to a billion genetically-modified mosquito eggs per week.

Two physicians from UCSF call on the medical Accreditation Council to raise the bar on how it determines physicians can be trained.

The leading medical institution announced two partnerships to make its insight more accessible.

LifeMine champions its “genomically-enabled drug discovery engine” that combines artificial intelligence with synthetic biology.

Marco Huesch speaks on “cozy duopolies and oligopolies” in regional healthcare markets, and what it may take for analytics innovation to thrive.

“Sometimes we realize, 'Watson got that one right and we got it wrong," one of its trainers at MSKCC said. Still, it has work to do.

"It improves how kidneys are allocated, and it improves the rationalizations of doctors and patients."

The application receives marketing authorization as a device, and is not intended for treatment of opiate dependence.

As Amazon threatens both retail sales and a pharmacy play, Target seems to intent on building its own retail-pharmacy-provider ecosystem.

Novartis joins other pharma companies looking to use the iPhone's sensory capabilities to study movement-related conditions.